Amber Implants, a Netherlands-based medical technology company, announced the appointment of Vincent Gardès as Chief Executive Officer, following his four years as Chairman of the Board.
The leadership change coincides with FDA clearance of Amber’s VCFix Spinal System, marking its transition from research and development to market readiness.
Subscribe to continue reading
- Unlimited access to our content and archive
- Exclusive access to our newsletter
- Join the Conversation! Exclusive access to article comments.
